150 related articles for article (PubMed ID: 8010261)
1. MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model.
Krueck WG; Schmiedl UP; Maravilla KR; Spence AM; Starr FL; Kenney J
AJNR Am J Neuroradiol; 1994 Apr; 15(4):625-32. PubMed ID: 8010261
[TBL] [Abstract][Full Text] [Related]
2. Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR.
Schmiedl UP; Kenney J; Maravilla KR
AJNR Am J Neuroradiol; 1992; 13(1):5-14. PubMed ID: 1595491
[TBL] [Abstract][Full Text] [Related]
3. Intracranial meningeomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging.
Hawighorst H; Engenhart R; Knopp MV; Brix G; Grandy M; Essig M; Miltner P; Zuna I; Fuss M; van Kaick G
Magn Reson Imaging; 1997; 15(4):423-32. PubMed ID: 9223043
[TBL] [Abstract][Full Text] [Related]
4. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA.
Kenney J; Schmiedl U; Maravilla K; Starr F; Graham M; Spence A; Nelson J
Magn Reson Med; 1992 Sep; 27(1):68-75. PubMed ID: 1435211
[TBL] [Abstract][Full Text] [Related]
5. Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double-echo dynamic MR imaging sequence.
Kuperman VY; Karczmar GS; Blomley MJ; Lewis MZ; Lubich LM; Lipton MJ
J Magn Reson Imaging; 1996; 6(5):764-8. PubMed ID: 8890014
[TBL] [Abstract][Full Text] [Related]
6. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
[TBL] [Abstract][Full Text] [Related]
7. Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings.
Roman-Goldstein SM; Barnett PA; McCormick CI; Ball MJ; Ramsey F; Neuwelt EA
AJNR Am J Neuroradiol; 1991; 12(5):885-90. PubMed ID: 1950917
[TBL] [Abstract][Full Text] [Related]
8. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
Yuh WT; Halloran JI; Mayr NA; Fisher DJ; Nguyen HD; Simonson TM
J Magn Reson Imaging; 1994; 4(3):243-9. PubMed ID: 8061421
[No Abstract] [Full Text] [Related]
9. Magnetic resonance imaging detection of extraluminal enterally administered gadopentetate dimeglumine in a rat model of intestinal ischemia.
Montalbano JM; Lee FT; Grist TM; Rappe AH; Weiss JW; Kelcz F; Gribenko V
Acad Radiol; 1996 Jun; 3(6):486-92. PubMed ID: 8796706
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.
Kovar DA; Lewis MZ; River JN; Lipton MJ; Karczmar GS
Magn Reson Med; 1997 Aug; 38(2):259-68. PubMed ID: 9256106
[TBL] [Abstract][Full Text] [Related]
11. Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.
Alhassan A; Weinmann HJ
AJNR Am J Neuroradiol; 1997 Apr; 18(4):785-6; author reply 786-8. PubMed ID: 9127052
[No Abstract] [Full Text] [Related]
12. Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves.
Andersen C; Taagehøj JF; Mühler A; Rehling M
Magn Reson Imaging; 1996; 14(3):235-41. PubMed ID: 8725189
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors.
Zhang T; Matsumura A; Yamamoto T; Yoshida F; Nose T; Shimojo N
AJNR Am J Neuroradiol; 2002 Jan; 23(1):15-8. PubMed ID: 11827870
[TBL] [Abstract][Full Text] [Related]
14. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.
Wenz F; Rempp K; Hess T; Debus J; Brix G; Engenhart R; Knopp MV; van Kaick G; Wannenmacher M
AJR Am J Roentgenol; 1996 Jan; 166(1):187-93. PubMed ID: 8571873
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
Schwickert HC; Stiskal M; Roberts TP; van Dijke CF; Mann J; Mühler A; Shames DM; Demsar F; Disston A; Brasch RC
Radiology; 1996 Mar; 198(3):893-8. PubMed ID: 8628889
[TBL] [Abstract][Full Text] [Related]
18. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging.
Gowland P; Mansfield P; Bullock P; Stehling M; Worthington B; Firth J
Magn Reson Med; 1992 Aug; 26(2):241-58. PubMed ID: 1513249
[TBL] [Abstract][Full Text] [Related]
19. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA
J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors.
Wilkins DE; Raaphorst GP; Saunders JK; Sutherland GR; Smith IC
Magn Reson Imaging; 1995; 13(1):89-96. PubMed ID: 7898284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
